Rachel Kessler

Rachel Kessler is an experienced professional in the clinical research field, currently serving as a Study Manager at Xeris Pharmaceuticals, Inc. since November 2018. Prior to this role, Rachel held the position of Lead Clinical Oversight Manager at CSL Behring from February 2017 to October 2018. Earlier in the career, Rachel was a Regional Senior Clinical Trial Manager and served as a Certified Regional Clinical Research Associate II/Lead CRA at Galderma from June 2008 to December 2015. Rachel began the professional journey as a CRA at CollaGenex Pharmaceuticals and PHARMANET, and also worked as a Regulatory Specialist at the Coalition of Cancer Cooperative Groups. Rachel earned a degree from Penn State University between 1999 and 2003.